Lixte Biotechnology Inc.

NASDAQ: LIXT · Real-Time Price · USD
3.56
-0.34 (-8.72%)
At close: Aug 15, 2025, 3:59 PM
3.62
1.69%
After-hours: Aug 15, 2025, 05:16 PM EDT

Lixte Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-774.81K -706.94K -613K -983.26K -1.01M -967K -1.03M -1.02M -1.67M -1.37M -1.63M -1.48M -1.55M -1.65M -2.02M -1.24M -1.73M -1.73M
Interest Income
365.00 441.00 519.00 1.44K 2.23K 2.86K 3.95K 5.81K 2.71K 5.01K 6.98K 3.91K 191.00 109.00 139.00 161.00 180.00 146.00
Pretax Income
-775.67K -709.55K -618K -986.03K -1.01M -971K -1.03M -1.02M -1.67M -1.37M -1.63M -1.48M -1.55M -1.66M -2.03M -1.24M -1.73M -1.73M
Net Income
-775.67K -709.55K -618K -986.03K -1.01M -971K -1.03M -1.02M -1.67M -1.37M -1.63M -1.48M -1.55M -1.66M -2.03M -1.24M -1.73M -1.73M
Selling & General & Admin
714.16K 615.48K 578.67K 621.63K 798.45K 847.82K 876.84K 891.69K 862.57K 1.18M 1.18M 1.21M 1.11M 1.2M 1.22M 1.01M 1.47M 1.28M
Research & Development
60.65K 91.46K 34.83K 361.63K 210.71K 119.06K 149.07K 132.49K 427.46K 189.09K 453.62K 272.39K 164.81K 458.45K 803.65K 227.18K 262.42K 443.53K
Other Expenses
n/a n/a n/a n/a -156 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
774.81K 706.94K 613.5K 983.26K 1.01M 966.88K 1.03M 1.02M 1.67M 1.37M 1.63M 1.48M 1.55M 1.65M 2.02M 1.24M 1.73M 1.73M
Interest Expense
-1.81K 3.13K 4.43K 1.05K 4.15K 7.19K 10.14K 279.00 1.95K 3.86K 3.63K 2.12K 627.00 2.49K 4.47K n/a 845.00 2.11K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
774.81K 706.94K 613.5K 983.26K 1.01M 966.88K 1.03M 1.02M 1.67M 1.37M 1.63M 1.48M 1.55M 1.65M 2.02M 1.24M 1.73M 1.73M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a -1.02K -766 1.37K -5.21K -2.61K n/a 72.00 -58 -161 n/a n/a
Shares Outstanding (Basic)
2.72M 2.47M 2.25M 2.25M 2.25M 2.25M 2.25M 2.07M 1.67M 1.66M 1.67M 1.66M 1.62M 1.37M 1.37M 1.37M 1.36M 1.28M
Shares Outstanding (Diluted)
2.72M 2.47M 2.25M 2.25M 2.25M 2.25M 2.25M 2.07M 1.67M 1.66M 1.67M 1.66M 1.62M 1.37M 1.37M 1.37M 1.36M 1.28M
EPS (Basic)
-0.29 -0.29 -0.27 -0.44 -0.45 -0.43 -0.46 -0.49 -1 -0.82 -0.98 -0.89 -0.95 -1.2 -1.48 -0.9 -1.27 -1.35
EPS (Diluted)
-0.29 -0.29 -0.27 -0.44 -0.45 -0.43 -0.46 -0.49 -1 -0.82 -0.98 -0.89 -0.95 -1.2 -1.48 -0.9 -1.27 -1.35
EBITDA
-774.81K -706.42K -1.57M -984.98K -1.01M -971.32K -1.02M -1.02M 1.64K 2.49K -1.63M 492.00 -294 -2.57K -4.41K -1.24M -571 -1.96K
EBIT
-775.67K -706.42K -613K -984.98K -1.01M -964K -1.02M -1.02M -1.67M -1.36M -1.63M -1.48M -1.55M -1.65M -2.02M -1.24M -1.73M -1.73M
Depreciation & Amortization
n/a 706.94K -965K -1.72K 29.84K -12.28K n/a n/a 1.67M 1.37M 1.63M 1.48M 1.55M 1.65M 2.02M 1.24M 1.73M 1.73M